Cardiac hypertrophy is inhibited by antagonism of ADAM12 processing of HB-EGF: Metalloproteinase inhibitors as a new therapy - Concepedia

Concepedia

Publication | Closed Access

Cardiac hypertrophy is inhibited by antagonism of ADAM12 processing of HB-EGF: Metalloproteinase inhibitors as a new therapy

718

Citations

20

References

2002

Year

Masanori Asakura, Masafumi Kitakaze, Seiji Takashima, Yulin Liao, Fuminobu Ishikura, Tsuyoshi Yoshinaka, Hiroshi Ohmoto, Koichi Node, Hiroshi Ishiguro, Hiroshi Asanuma,

Nature Medicine

Adam12 ProcessingCardiac MuscleCardiomyopathyHeart FailureCardiovascular DiseaseMedicinePhysiologyCardiovascular PharmacologyNew TherapyCardiac HypertrophyPharmacologyCardiology

References

	Year	Citations

Page 1

Page 1